Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids. HealthDay News — In a clinical practice guideline issued ...

Real-world data from 2016 to 2025 highlight the changing landscape of biologic use and the growing preference for tezepelumab in asthma.

Please provide your email address to receive an email when new articles are posted on . The questionnaire assessed general fatigue, sleep-rest fatigue and cognitive fatigue. Asthma-related quality of ...

Rochester, Minn.-based Mayo Clinic researchers have developed AI tools to help identify young children at highest risk for severe asthma and acute respiratory infections. The tools use machine ...

Add Yahoo as a preferred source to see more of our stories on Google. Everyone coughs and sneezes occasionally, and it's hard to get through peak upper-respiratory virus season without catching a cold ...

BOSTON -- Patients with severe, uncontrolled asthma had significantly higher odds of improvement in asthma-related sleep disturbances and improvement in activity levels when treated with tezepelumab ...

Exposure to more germs may backfire for adult asthma sufferers In A Nutshell A new mouse study from Cornell University found that adult mice exposed to a wide variety of microbes developed more severe ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...